Retrospective evaluation of combined modality treatment and prognostic factors in patients with esophageal cancer

Acta Oncologica

Volumn 44, Issue 2, 2005, Pages 168-173

  Neuhof, Dirk ^a   Neumayer, Florian ^a   Einbeck, Wolfgang ^b   Haschemian, Kai ^b   Mai, Sabine K ^b   Hochhaus, Andreas ^b   Willeke, Frank ^b   Rudi, Jochen ^c   Debus, Jürgen ^a   Wenz, Frederik ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Theresienkrankenhaus Mannheim ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIATION DOSAGE; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 20244365200     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860510029563     Document Type: Article

References (20)

1. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma. I. A critical review of surgery. Br J Surg 1980;67:381-90.
2. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma. II. A critical review of radiotherapy. Br J Surg 1980;67:457-61.
3. Fritz P, Wannenmacher M. Die Strahlenbehandlung in der multimodalen Therapie des Ösophaguskarzinoms. Strahlenther Onkol 1997;173:295-308.
4. Bollschweiler E, Holscher AH. sophaguskarzinom - aktuelle Epidemiologie in Deutschland. Onkologie 2001;24(2):180-4.
5. Samel S, Hofheinz R, Hundt A, et al. Neoadjuvant radiochemotherapy of adenocarcinoma of the oesophagogastric junction. Onkologie 2001;24:278-82.
6. Wenz F, Mamon H. Perioperative radiotherapy for cancer of the esophagus. Sem Surg Oncol 2001;20:33-9.
7. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
8. Al-Sarraf M, Martz K, Herskovic, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997;15:277-84.
9. Vaupel P, Kelleher DK, Höckel M. Oxygen status of malignant tumors: Pathogenesis of hypoxia and significancy for tumor therapy. Semin Oncol 2001;28(2 Suppl 8):29-35.
10. Overgaard J, Hansen HS, Overgaard M, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 1998;46(2):135-46.
11. Schäfer U, Micke O, Müller SB, Schüller P, Willich N. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. Sitrahlenther Onkol 2003;179:527-34.
12. Höckel M, Schienger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56(19):4509-15.
13. Hussey DH, Barakley T, Bloedorn F. Carcinoma of the esophagus. In: Fletcher GH, editor. Textbook of Radiotherapy. 3rd ed. Philadelphia: Lea & Febiger; 1980:688.
14. Pearson JG. The present status and future potential of radiotherapy in the management of esophageal cancer. Cancer 1977;39(2 Suppl):882-90.
15. Taussky D, Rousson V, Pescia R. Clinical markers of hypoxia and other predictive factors of survival in conservative therapy of squamous-cell carcinoma of the esophagus. Int J Colorectal Dis 2003;18:167-71.
16. Dreilich M, Bergstrom S, Wagenius G, Brattstrom D, Bergqvist M. A retrospective study focusing on clinical predictive factors in patients with oesophageal carcinoma. Anticancer Res 2004;24:1915-20.
17. Thews O, König R, Kelleher DK, Kutzner J, Vaupel P. Enhanced radiosensitivity in experimental tumors following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer 1998;78:752-6.
18. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet; 362:1255-60.
19. Mücke R, Ziegler PG, Libera T, Klautke G, Fietkau R. Multimodale Therapie des fortgeschrittenen inoperablen Ösophaguskarzinoms. Eine retrospektive Analyse. Strahlenther Onkol 2000;176:350-5.
20. Rebecca W, Richard M. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus (Cochrane Review). Cochrane Database Syst Rev 2001;2:CD002092.